麻痺(Paralysis):グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Paralysis Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Paralysis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Paralysis to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Paralysis to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Paralysis 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Paralysis Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Stemedica Cell Technologies, Inc. 32
Clinical Trial Overview of Stemedica Cell Technologies, Inc. 32
Teva Pharmaceutical Industries Limited 33
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 33
Teijin Limited 34
Clinical Trial Overview of Teijin Limited 34
ReNeuron Group plc 35
Clinical Trial Overview of ReNeuron Group plc 35
MacroGenics, Inc. 36
Clinical Trial Overview of MacroGenics, Inc. 36
Emergent BioSolutions Inc. 37
Clinical Trial Overview of Emergent BioSolutions Inc. 37
Bayer AG 38
Clinical Trial Overview of Bayer AG 38
Asahi Kasei Corporation 39
Clinical Trial Overview of Asahi Kasei Corporation 39
Clinical Trial Overview of Top Institutes / Government 40
National Institute of Neurological Disorders and Stroke 40
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 40
U.S. Department of Veterans Affairs 41
Clinical Trial Overview of U.S. Department of Veterans Affairs 41
Assistance Publique – Hopitaux de Paris 42
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 42
University of Miami 43
Clinical Trial Overview of University of Miami 43
University of Florida 44
Clinical Trial Overview of University of Florida 44
National Cancer Institute 45
Clinical Trial Overview of National Cancer Institute 45
Hadassah Medical Organization 46
Clinical Trial Overview of Hadassah Medical Organization 46
Medical University of Vienna 47
Clinical Trial Overview of Medical University of Vienna 47
Rouen University Hospital 48
Clinical Trial Overview of Rouen University Hospital 48
Imperial College London 49
Clinical Trial Overview of Imperial College London 49
Five Key Clinical Profiles 50
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Disclaimer 76
Source 76


【レポート販売概要】

■ タイトル:麻痺(Paralysis):グローバル臨床試験レビュー(2014年上半期)
■ 英文:Paralysis Global Clinical Trials Review, H1, 2014
■ 発行日:2014年6月20日
■ 調査会社:GlobalData
■ 商品コード:GDHC2210CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。